Bengt Hallengren

2.5k total citations
64 papers, 1.8k citations indexed

About

Bengt Hallengren is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Bengt Hallengren has authored 64 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Molecular Biology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Bengt Hallengren's work include Thyroid Disorders and Treatments (30 papers), Thyroid Cancer Diagnosis and Treatment (12 papers) and Ophthalmology and Eye Disorders (10 papers). Bengt Hallengren is often cited by papers focused on Thyroid Disorders and Treatments (30 papers), Thyroid Cancer Diagnosis and Treatment (12 papers) and Ophthalmology and Eye Disorders (10 papers). Bengt Hallengren collaborates with scholars based in Sweden, Denmark and United States. Bengt Hallengren's co-authors include Mikael Lantz, Arne Melander, Mikael Lantz, Göran Wallin, Mirna Abraham‐Nordling, Peter Åsman, Ove Törring, Jan Calissendorff, Arne Forsgren and Leif Groop and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Journal of Internal Medicine.

In The Last Decade

Bengt Hallengren

63 papers receiving 1.7k citations

Peers

Countries citing papers authored by Bengt Hallengren

Since Specialization

Citations

This map shows the geographic impact of Bengt Hallengren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Hallengren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Hallengren more than expected).

Fields of papers citing papers by Bengt Hallengren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt Hallengren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Hallengren. The network helps show where Bengt Hallengren may publish in the future.

Co-authorship network of co-authors of Bengt Hallengren

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt Hallengren. A scholar is included among the top collaborators of Bengt Hallengren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt Hallengren. Bengt Hallengren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Outcome of Graves' Disease: A Gender Perspective 2023 ·Women s Health Reports ·Jan Calissendorff, Per Karkov Cramon, Bengt Hallengren, (unknown), Mikael Lantz, Tereza Planck, Gabriel Sjölin, Göran Wallin, Mats Holmberg	4
2	The Long-Term Outcome of Treatment for Graves' Hyperthyroidism 2019 ·Thyroid ·Gabriel Sjölin, Mats Holmberg, Ove Törring, (unknown), (unknown), (unknown), Mirna Abraham‐Nordling, Jan Calissendorff, Mikael Lantz, Bengt Hallengren, Helena Filipsson Nyström, Göran Wallin	64
3	Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey 2019 ·Thyroid ·Ove Törring, Torquil Watt, Gabriel Sjölin, (unknown), Mirna Abraham‐Nordling, Jan Calissendorff, Per Karkov Cramon, Helena Filipsson Nyström, Bengt Hallengren, Mats Holmberg, (unknown), Mikael Lantz, Göran Wallin	64
4	Adjuvant Treatment of Graves' Disease with Diclofenac: Safety, Effects on Ophthalmopathy and Antibody Concentrations 2016 ·European Thyroid Journal ·Mikael Lantz, Jan Calissendorff, Frank Träisk, Leif Tallstedt, Tereza Planck, Ove Törring, Bengt Hallengren, Peter Åsman	9
5	Presence of Thyroid-Stimulating Hormone Receptor Antibodies in a Patient with Subacute Thyroiditis followed by Hypothyroidism and Later Graves' Disease with Ophthalmopathy: A Case Report 2015 ·European Thyroid Journal ·Bengt Hallengren, Tereza Planck, Peter Åsman, Mikael Lantz	7
6	Smoking Induces Overexpression of Immediate Early Genes in Active Graves' Ophthalmopathy 2014 ·Thyroid ·Tereza Planck, (unknown), Hemang Parikh, Kristoffer Ström, Peter Åsman, Håkan Brorson, Bengt Hallengren, Mikael Lantz	30
7	Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine 2010 ·European Journal of Endocrinology ·Mirna Abraham‐Nordling, Göran Wallin, Frank Träisk, Gertrud E. B. Berg, Jan Calissendorff, Bengt Hallengren, Pavo Hedner, Mikael Lantz, Ernst Nyström, Peter Åsman, G. E. F. Lundell, Ove Törring, (unknown)	26
8	Thyroid-Associated Ophthalmopathy after Treatment for Graves’ Hyperthyroidism with Antithyroid Drugs or Iodine-131 2009 ·The Journal of Clinical Endocrinology & Metabolism ·Frank Träisk, Leif Tallstedt, Mirna Abraham‐Nordling, Tommy Andersson, Gertrud E. B. Berg, Jan Calissendorff, Bengt Hallengren, Pavo Hedner, Mikael Lantz, Ernst Nyström, Vesna Ponjavic, Adam Taube, Ove Törring, Göran Wallin, Peter Åsman, G. E. F. Lundell, (unknown)	172
9	SARCOIDOSIS AND AUTOIMMUNITY: EVIDENCE OF DIFFERENTIAL ASSOCIATIONS WITH HLA CLASS II MARKERS 2006 ·International Journal of Endocrinology and Metabolism ·Konstantinos I. Papadopoulos, Ralf Waßmuth, (unknown), Klas Sjöberg, Bengt Hallengren	6
10	Overexpression of Immediate Early Genes in Active Graves’ Ophthalmopathy 2005 ·The Journal of Clinical Endocrinology & Metabolism ·Mikael Lantz, (unknown), Hemang Parikh, (unknown), Martin Ridderstråle, Peter Åsman, Magnus Åberg, Leif Groop, Bengt Hallengren	52
11	Gender differences in GAD antibody – positive diabetes mellitus in relation to age at onset, C‐peptide and other endocrine autoimmune diseases 2004 ·Diabetes/Metabolism Research and Reviews ·Eero Lindholm, Bengt Hallengren, Carl‐David Agardh	27
12	Glutamic Acid Decarboxylase Antibody Positivity Is Associated with an Impaired Insulin Response to Glucose and Arginine in Nondiabetic Patients with Autoimmune Thyroiditis 2002 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), (unknown), Bengt Hallengren, Leif Groop, (unknown)	15
13	Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes 2001 ·Diabetes Obesity and Metabolism ·Anders Jönsson, Bengt Hallengren, Tony Rydberg, Arne Melander	26
14	Pharmacodynamics and pharmacokinetics of intravenous glibenclamide in Caucasian and Chinese patients with type-2 diabetes 2000 ·European Journal of Clinical Pharmacology ·Anders Jönsson, Juliana C.N. Chan, Tony Rydberg, Stein Vaaler, Bengt Hallengren, Clive S. Cockram, Julia Critchley, Arne Melander	15
15	No increase in fracture incidence in patients treated for thyrotoxicosis in Malmö during 1970–74. A 20‐year population‐based follow‐up * 1999 ·Journal of Internal Medicine ·Bengt Hallengren, Barbara Elmståhl, J Berglund, Svend Borup Christensen, Sölve Elmståhl, Olof Johnell, K.‐G. Thorngren	7
16	[Hypothyroidism--clinical findings, diagnosis, therapy. Thyroid tests should be performed on broad indications]. 1998 ·PubMed ·Bengt Hallengren	10
17	The occurrence of polyglandular autoimmune syndrome type III associated with coeliac disease in patients with sarcoidosis 1994 ·Journal of Internal Medicine ·Konstantinos I. Papadopoulos, (unknown), Bengt Hallengren	16
18	Increased arterial and venous plasma noradrenaline levels in patients with primary hypothyroidism during hypothyroid as compared to euthyroid state 1992 ·Journal of Endocrinological Investigation ·Per Manhem, Margareta Bramnert, Bengt Hallengren, (unknown), (unknown)	17
19	Total and age‐specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmö 1970–74 1990 ·Journal of Internal Medicine ·Johan Berglund, Svend Borup Christensen, Bengt Hallengren	41
20	Normal visual fields as assessed by computerized static threshold perimetry in patients with untreated primary hypothyroidism 1989 ·European Journal of Endocrinology ·Bengt Hallengren, (unknown), Margareta Bramnert, Inga Redlund-Johnell, Anders Heijl	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact